RESTON, Va., June 21, 2017 /PRNewswire/ -- Leidos (NYSE: LDOS), a FORTUNE 500® science and technology company, was awarded a prime position on the Strategic Partners Acquisition Readiness Contract (SPARC) vehicle by the Centers for Medicare & Medicaid Services (CMS). The multiple-award indefinite-delivery/indefinite-quantity (IDIQ) contract has a five-year period of performance and a total contract value of $25 billion for all awardees, if all options are exercised. Leidos is one of 62 contractors eligible to compete for task orders under the contract. Work will be performed primarily in Windsor Mill, Md.
SPARC provides strategic, technical, and program management guidance and support services to facilitate the modernization of business processes and supporting systems. Under the contract, Leidos will apply technical expertise in various professional services including design, development, requirement, testing, security control assessment, and independent verification and validation.
"We have extensive experience in providing innovative technology services and we look forward to continuing a tradition of excellence through the SPARC vehicle," said Leidos Health Group President, Jon Scholl.
Leidos is a FORTUNE 500® science and technology solutions and services leader working to solve the world's toughest challenges in the defense, intelligence, homeland security, civil, and health markets. The company's 32,000 employees support vital missions for government and commercial customers. Headquartered in Reston, Virginia, Leidos reported annual revenues of approximately $7.04 billion for the fiscal year ended December 30, 2016. For more information, visit www.Leidos.com.
Statements in this announcement, other than historical data and information, constitute forward-looking statements that involve risks and uncertainties. A number of factors could cause our actual results, performance, achievements, or industry results to be very different from the results, performance, or achievements expressed or implied by such forward-looking statements. Some of these factors include, but are not limited to, the risk factors set forth in the company's Annual Report on Form 10-K for the period ended December 30, 2016, and other such filings that Leidos makes with the SEC from time to time. Due to such uncertainties and risks, readers are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/centers-for-medicare--medicaid-services-awards-leidos-spot-on-strategic-partners-acquisition-readiness-contract-300477846.html